A resolution to declare May 5-9, 2025, as Tardive Dyskinesia Awareness Week in the state of Michigan.
Impact
The passage of HR0082 places a focus on the importance of early detection and intervention in managing TD. It operationalizes routine screenings by encouraging healthcare providers, patients, and care partners to discuss TD risks and symptoms. This initiative aligns with the American Psychiatric Association's clinical guidelines, promoting proactive healthcare measures to improve the quality of life for those affected by TD.
Summary
House Resolution 82 aims to declare May 5-9, 2025, as Tardive Dyskinesia Awareness Week in the state of Michigan. The resolution underscores the significance of Tardive Dyskinesia (TD), a condition caused by prolonged use of antipsychotic medications, which can lead to uncontrollable movements. The House recognizes the rising rates of antipsychotic prescribing among individuals dealing with serious mental illnesses, emphasizing the need for better awareness regarding TD, especially among at-risk populations such as older adults and those with specific health backgrounds.
Contention
While HR0082 is primarily a resolution focused on awareness, it serves to highlight critical issues surrounding the treatment of mental health conditions with antipsychotic medications. One notable point of contention is the underdiagnosis of TD, as an estimated 60% of individuals living with the condition remain undiagnosed. Moreover, the resolution addresses the stigma associated with TD, indicating a cultural need for better understanding and supportive measures within healthcare practices regarding patients prescribed antipsychotics.